Display Settings:

Format

Send to:

Choose Destination
    Rom J Intern Med. 1992 Jan-Mar;30(1):39-44.

    Immunoglobulins and complement components levels in patients with lung cancer.

    Source

    Department of Biochemistry and Chemistry, Silesian Medical Academy, Katowice, Poland.

    Abstract

    Sera from 96 patients with lung cancer were assayed in order to evaluate the concentrations of IgG, IgA, IgM, C3c and C4. Histologically, 49 of the patients had squamous cell carcinoma, 11--adenocarcinoma, 20--small cell carcinoma and 16--not identified lung cancer. No statistically significant differences were found between the concentrations of IgG and IgM in patients with carcinoma of the lung versus subjects in the control group. Both serum IgA and complement components (C30 and C4) were significantly elevated in almost all patients from the tumor group as compared with the levels in the control group.

    PMID:
    1323139
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk